There are four types of
polycystic ovary syndrome: Insulin-resistant polycystic ovary syndrome,
inflammatory polycystic ovary syndrome, hidden-cause polycystic ovary syndrome,
and pill-induced polycystic ovary syndrome.
Statistics:
The global Polycystic
Ovary Syndrome Treatment Market is estimated to account for US$ 945.1 Mn in
terms of value and is expected to reach US$ 1,311.0 Mn by the end of 2027.
Global Polycystic Ovary Syndrome
Treatment Market: Drivers
Increasing funding for R&D is
expected to propel growth of the global polycystic ovary syndrome treatment
market over the forecast period. For instance, in 2019, Wellcome Trust funded a
US$ 3 million project that observed 1,000 women suffering from polycystic ovary
syndrome in three studies including the testing of a new drug.
Global Polycystic Ovary Syndrome Treatment
Market: Opportunities
Launch of branded products as a
direct treatment for polycystic ovary syndrome is expected to offer lucrative
growth opportunities for players in the global polycystic ovary syndrome
treatment market. Currently, there are no drugs approved by FDA and EMA for the
treatment of polycystic ovary syndrome. Thus, drug manufacturers are being
presented the opportunity to hold significant share in the market.
* The sample copy includes: Report Summary, Table of
Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.
Request a sample copy
of this report: https://www.coherentmarketinsights.com/insight/request-sample/1589
Global Polycystic Ovary Syndrome
Treatment Market: Restraints
Lower diagnosis rate in
underdeveloped economies is expected to hinder growth of the global polycystic
ovary syndrome treatment market. Awareness regarding polycystic ovary syndrome
and its symptoms among populations in underdeveloped economies is significantly
low.
Key Takeaways:
The global polycystic ovary
syndrome treatment market was valued at US$ 904.7 Mn in 2019 and is forecast to
reach a value of US$ 1,311.0 Mn by 2027 at a CAGR of 4.8% between 2020 and
2027. Major factor driving the growth of global polycystic ovary syndrome
treatment market during the forecast period include high prevalence of
polycystic ovary syndrome, and research and development.
Insulin Sensitizing Agents held
dominant position in the global polycystic ovary syndrome treatment market in
2019, accounting for 32.9% share in terms of value, followed by Aromatase
Inhibitors & SERMs and Oral contraceptives, respectively.
Market Trends
Increasing awareness regarding
polycystic ovary syndrome is expected to propel growth of the global polycystic
ovary syndrome treatment market. For instance, in September 2019, SIHF
Healthcare, U.S. raised awareness of polycystic ovary syndrome on the occasion
of Polycystic Ovary Syndrome (PCOS) Awareness Month.
Browse Research
Report: https://www.coherentmarketinsights.com/market-insight/polycystic-ovarian-syndrome-treatment-market-1589
Moreover, R&D in polycystic
ovary syndrome is also expected to aid in growth of the market. For instance,
in 2018, an international consortium, including researchers at the Icahn School
of Medicine at Mount Sinai, conducted a whole genome association study to
identify common genetic architecture for different diagnostic criteria used to
define polycystic ovary syndrome.
Global Polycystic Ovary Syndrome
Treatment Market: Competitive Landscape
Major players operating in the
global polycystic ovary syndrome treatment market include, Sanofi, Novartis AG,
Teva Pharmaceutical Industries Limited, Addex Therapeutics Ltd., BIOCAD, Merck
KGaA, AstraZeneca plc., Bristol Myers Squibb Co., Ferring Pharmaceuticals,
Inc., and Crinetics Pharmaceuticals, Inc.
Global Polycystic Ovary Syndrome
Treatment Market: Key Developments
Major players in the global
polycystic ovary syndrome treatment market are focused on adopting M&A
strategies to expand their product portfolio. For instance, in August 2020,
Bayer AG acquired U.K.-based KaNDy Therapeutics and its investigational treatment
for menopause with a US$ 425 million upfront payment, in order to expand its
women’s healthcare pipeline.
Buy-Now this research
report: https://www.coherentmarketinsights.com/insight/buy-now/1589
About
Coherent Market Insights:
Coherent
Market Insights is a prominent market research and consulting firm offering
action-ready syndicated research reports, custom market analysis, consulting
services, and competitive analysis through various recommendations related to
emerging market trends, technologies, and potential absolute dollar
opportunity.
Contact
Us:
mailto:sales@coherentmarketinsights.com
U.S.
Office:
Name: Mr. Shah
Coherent
Market Insights 1001 4th Ave,
# 3200
Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN
: +050-5539-1737
No comments:
Post a Comment